Bausart, M.; Bozzato, E.; Joudiou, N.; Koutsoumpou, X.; Manshian, B.; Préat, V.; Gallez, B.
Mismatch between Bioluminescence Imaging (BLI) and MRI When Evaluating Glioblastoma Growth: Lessons from a Study Where BLI Suggested “Regression” while MRI Showed “Progression”. Cancers 2023, 15, 1919.
https://doi.org/10.3390/cancers15061919
AMA Style
Bausart M, Bozzato E, Joudiou N, Koutsoumpou X, Manshian B, Préat V, Gallez B.
Mismatch between Bioluminescence Imaging (BLI) and MRI When Evaluating Glioblastoma Growth: Lessons from a Study Where BLI Suggested “Regression” while MRI Showed “Progression”. Cancers. 2023; 15(6):1919.
https://doi.org/10.3390/cancers15061919
Chicago/Turabian Style
Bausart, Mathilde, Elia Bozzato, Nicolas Joudiou, Xanthippi Koutsoumpou, Bella Manshian, Véronique Préat, and Bernard Gallez.
2023. "Mismatch between Bioluminescence Imaging (BLI) and MRI When Evaluating Glioblastoma Growth: Lessons from a Study Where BLI Suggested “Regression” while MRI Showed “Progression”" Cancers 15, no. 6: 1919.
https://doi.org/10.3390/cancers15061919
APA Style
Bausart, M., Bozzato, E., Joudiou, N., Koutsoumpou, X., Manshian, B., Préat, V., & Gallez, B.
(2023). Mismatch between Bioluminescence Imaging (BLI) and MRI When Evaluating Glioblastoma Growth: Lessons from a Study Where BLI Suggested “Regression” while MRI Showed “Progression”. Cancers, 15(6), 1919.
https://doi.org/10.3390/cancers15061919